Sonablate HIFU for Prostate Tissue Ablation
Prostate Cancer / Diseased Prostate Tissue
Key Facts
About Sonablate
Sonablate Corp., founded in 2004 and headquartered in Charlotte, North Carolina, is a pioneer and commercial leader in High-Intensity Focused Ultrasound (HIFU) for the focal treatment of prostate cancer and other prostate diseases. The company's Sonablate HIFU system offers a customizable, incision-free alternative to radical prostatectomy or radiation, aiming to preserve patient quality of life while providing effective disease control. With over 30,000 patients treated worldwide and FDA clearance secured in 2015, Sonablate has established a significant global footprint. The company operates as a private commercial-stage entity, generating revenue from the sale of its medical device platform to urology clinics and hospitals.
View full company profile